Divi's Laboratories Limited (DIVISLAB.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.58T |
| Enterprise Value | 1.58T |
| P/E Ratio | 83.12 |
| PEG Ratio | 3.09 |
| Price/Sales Ratio | 21.66 |
| Price/Book Ratio | 14.51 |
| Enterprise/Revenue | 21.66 |
| Enterprise/EBITDA | 56.81 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.26 |
| Operating Margin | 0.31 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.18 |
Income Statement
| Revenue | 105.6B |
| Revenue/Share | 423.02 |
| Gross Profit | 45.62B |
| EBITDA | 38.74B |
| Net Income | 25.68B |
| Diluted EPS | 96.75 |
Balance Sheet
| Total Cash | 32.33B |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 631.37 |
Price History
| 52-Week Change | 39.55 |
| 52-Week High | 9,740 |
| 52-Week Low | 5,647.5 |
| Moving Average 50 Days | 9,165.07 |
| Moving Average 200 Days | 7,227.93 |
Statistics
| Average Volume | 520,738 |
| Shares Outstanding | 265.47M |
| % Held by Institutions | 0.03 |
Dividend And Splits
| Trailing Annual Dividend Rate | 30 |
| Trailing Annual Dividend Yield | 0.33 |
| Payout Ratio | 0.27 |
| Last Split Factor | 2:1 |
| Last Split Date | September 23, 2015 |
AD
